Eventide Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Buy
38,166
+9,519
+33% +$3.26M 0.18% 135
2026
Q1
$10M Buy
28,647
+275
+1% +$98K 0.17% 140
2025
Q4
$9.32M Buy
28,372
+4,146
+17% +$1.32M 0.15% 147
2025
Q3
$6.67M Buy
24,226
+1,222
+5% +$354K 0.11% 137
2025
Q2
$6.7M Buy
23,004
+6,043
+36% +$1.71M 0.12% 138
2025
Q1
$5.23M Buy
16,961
+6,912
+69% +$2.04M 0.1% 143
2024
Q4
$2.61M Buy
10,049
+5,219
+108% +$1.55M 0.05% 161
2024
Q3
$1.56M Sell
4,830
-2,339
-33% -$765K 0.03% 170
2024
Q2
$2.24M Buy
7,169
+2,266
+46% +$666K 0.04% 148
2024
Q1
$1.39M Buy
+4,903
New +$1.43M 0.02% 148

Other funds holding AMGN

Eventide Asset Management's AMGN Position: Q2 2026 in Review

Eventide Asset Management increased its Amgen (AMGN) stake by 33% in Q2 2026, buying an estimated $3.26M and bringing the position to 38,166 shares worth $13.8M. The position accounts for 0.18% of the portfolio, ranked #135.

Eventide Asset Management first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Eventide Asset Management held 38,166 shares of Amgen worth $13.8M as of Q2 2026.
  • Eventide Asset Management bought 9,519 Amgen shares in Q2 2026, an estimated $3.26M.
  • Amgen made up 0.18% of Eventide Asset Management's portfolio in Q2 2026, its #135 holding.
  • Eventide Asset Management first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.